risperdal consta 375mg prá&scaron;ek a rozpou&scaron;tědlo pro injekční suspen - search results

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

risperdal quicklet

janssen-cilag (new zealand) ltd - risperidone 0.5mg - orodispersible tablet - 0.5 mg - active: risperidone 0.5mg excipient: aspartame carbomer gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

risperdal quicklet

janssen-cilag (new zealand) ltd - risperidone 1mg - orodispersible tablet - 1 mg - active: risperidone 1mg excipient: aspartame carbomer gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

risperdal quicklet

janssen-cilag (new zealand) ltd - risperidone 2mg; risperidone 2mg - orodispersible tablet - 2 mg - active: risperidone 2mg excipient: aspartame carbomer 934p gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide active: risperidone 2mg excipient: aspartame carbomer 934p gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide xanthan gum - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

risperdal quicklet

janssen-cilag (new zealand) ltd - risperidone 3mg - orodispersible tablet - 3 mg - active: risperidone 3mg excipient: aspartame carbomer 934p gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide xanthan gum - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

risperdal quicklet

janssen-cilag (new zealand) ltd - risperidone 4mg - orodispersible tablet - 4 mg - active: risperidone 4mg excipient: aspartame carbomer 934p gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide xanthan gum - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.